One of the greatest technological advancements in diabetes care has been the insulin pump. For one, it gives you the illusion of being "normal" because you no longer have to inject insulin throughout the day. Instead, you "bolus" by pushing a button on the pump itself or using a remote control. It allows better glucose management because you can adjust your basal rate (the "background" insulin dose) by increments of one thousandth of a unit every hour. Especially when you're moving from the peaks and valleys of NPH or the restraints and hazards of Lantus, the freedom of living with an insulin pump is incredible. But pumps do not come without their kinks.
RALEIGH, NC- DiabetesSisters is pleased to announce that registration for the 2012 Weekend for Women Conference opened on January 1, 2012, at 8 AM. The conference, a revolutionary weekend designed specifically for women with diabetes, will take place Friday, May 18, through Sunday, May 20, 2012, at the Marriott City Center in downtown Raleigh.
Minneapolis-based Medtronic, Inc., has announced that the US Food and Drug Administration has given it the go-ahead to market its mySentry monitor, which allows caregivers to check the blood sugar of a diabetic person sleeping in another room. The bedside monitor, which costs around $3,000, works in tandem with Medtronic's MiniMed Paradigm® REAL-Time RevelTM System, a combined insulin pump/continuous glucose monitor unit.
This year's DREAM Award, presented by the Disability Rights Legal Center (DRLC), was given to Nick Jonas, the musician and actor best known as one of the three Jonas Brothers. He was among the special recipients at the DRLC's annual Franklin D. Roosevelt Dinner, held this year on November 17, 2011.
How many times has this happened to you? You're driving somewhere and something feels off. You suspect that your blood sugar level may be dropping, but you plow ahead. Now, imagine your car sounding the alarm: "Attention: This is your car speaking. Your blood sugar is low. Pull over and eat a snack."
Medtronic and Ford Motor Company have teamed up to develop a prototype device that will allow people with diabetes to monitor their blood glucose levels as they drive. Using Bluetooth technology, the system will connect readings from Medtronic's continuous glucose monitor to Ford's onboard communications system, called "Sync."
Dr. Jonathan Beach is a 35-year-old emergency medicine physician who has had type 1 diabetes for 31 years. He owns and operates Urgicare, a wellness center that includes The Northeast Center for Diabetes Care and Education in Plattsburgh, New York, an isolated rural community that has few other resources for diabetes. This is his story of his life with diabetes and his professional experience with the insulin pump.
Recently, we published an article about the implantable pump "A Miracle Technology for Type 1s: Can It Be Saved?" Following the appearance of this article on the Diabetes Health website, over 100 readers commented, most of them expressing a heartfelt desire for access to this technology in the U.S.A. To read the original article click on link below: A Miracle Technology for Type 1s: Can It Be Saved?
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.